Cannabis Market in US 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	153 Pages	TechNavio	February, 2025	INF19639210

Best Price Guarantee
Price	from $2,500
Length	153 Pages
Publisher	TechNavio
Published Date	February, 2025
SKU	INF19639210

Cannabis Market In US 2025-2029

The cannabis market in US is forecasted to grow by USD 141.48 billion during 2024-2029, accelerating at a CAGR of 37.1% during the forecast period. The report on the cannabis market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing millennial population in key cannabis markets, increasing number of medical cannabis dispensaries, and health benefits of medical cannabis.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data. For further information on this report, please visit - https://www.technavio.com/report/report/us-cannabis-market-analysis

Technavio's cannabis market in US is segmented as below:

By Derivative Type

CBD
THC
Balanced THC and CBD

By Product

Medical
Recreational

By Source

Marijuana
Hemp

By Geographical Landscape

North America

This study identifies the increase in funding for research and production of medical marijuana as one of the prime reasons driving the cannabis market in US growth during the next few years. Also, use of advanced techniques in cannabis cultivation and launch of medical cannabis education programs will lead to sizable demand in the market.

The report on the cannabis market in US covers the following areas:

Cannabis Market in US sizing
Cannabis Market in US forecast
Cannabis Market in US industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cannabis market in US vendors that include Aurora Cannabis Inc., Canopy Growth Corp., Charlottes Web Holdings Inc., Columbia Care Inc., Cresco Labs LLC, Cronos Group Inc., Curaleaf Holdings Inc., Green Roads Inc., Jazz Pharmaceuticals PLC, Lexaria Bioscience Corp., Medical Marijuana Inc., Pure Spectrum CBD, Sundial Growers Inc., Terrascend Canada, Tilray Brands Inc., Trulieve Cannabis Corp., Unrivaled Brands Inc., and Verano Holdings LLC. Also, the cannabis market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Country Market Characteristics; Executive Summary - Chart on Market Segmentation by Derivative Type; Executive Summary - Chart on Market Segmentation by Product; Executive Summary - Chart on Market Segmentation by Source; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ billion); Data Table on US - Market size and forecast 2024-2029 ($ billion); Chart on US: Year-over-year growth 2024-2029 (%); Data Table on US: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Cannabis Market in US 2019 - 2023; Historic Market Size - Data Table on Cannabis Market in US 2019 - 2023 ($ billion); 5.2 Derivative Type segment analysis 2019 - 2023; Historic Market Size - Derivative Type Segment 2019 - 2023 ($ billion); 5.3 Product segment analysis 2019 - 2023; Historic Market Size - Product Segment 2019 - 2023 ($ billion); 5.4 Source segment analysis 2019 - 2023; Historic Market Size - Source Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis: 6.1 Impact of AI on Cannabis Market in US
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Derivative Type: 8.1 Market segments; Chart on Derivative Type - Market share 2024-2029 (%); Data Table on Derivative Type - Market share 2024-2029 (%); 8.2 Comparison by Derivative Type; Chart on Comparison by Derivative Type; Data Table on Comparison by Derivative Type; 8.3 CBD - Market size and forecast 2024-2029; Chart on CBD - Market size and forecast 2024-2029 ($ billion); Data Table on CBD - Market size and forecast 2024-2029 ($ billion); Chart on CBD - Year-over-year growth 2024-2029 (%); Data Table on CBD - Year-over-year growth 2024-2029 (%); 8.4 THC - Market size and forecast 2024-2029; Chart on THC - Market size and forecast 2024-2029 ($ billion); Data Table on THC - Market size and forecast 2024-2029 ($ billion); Chart on THC - Year-over-year growth 2024-2029 (%); Data Table on THC - Year-over-year growth 2024-2029 (%); 8.5 Balanced THC and CBD - Market size and forecast 2024-2029; Chart on Balanced THC and CBD - Market size and forecast 2024-2029 ($ billion); Data Table on Balanced THC and CBD - Market size and forecast 2024-2029 ($ billion); Chart on Balanced THC and CBD - Year-over-year growth 2024-2029 (%); Data Table on Balanced THC and CBD - Year-over-year growth 2024-2029 (%); 8.6 Market opportunity by Derivative Type; Market opportunity by Derivative Type ($ billion); Data Table on Market opportunity by Derivative Type ($ billion)
9 Market Segmentation by Product: 9.1 Market segments; Chart on Product - Market share 2024-2029 (%); Data Table on Product - Market share 2024-2029 (%); 9.2 Comparison by Product; Chart on Comparison by Product; Data Table on Comparison by Product; 9.3 Medical - Market size and forecast 2024-2029; Chart on Medical - Market size and forecast 2024-2029 ($ billion); Data Table on Medical - Market size and forecast 2024-2029 ($ billion); Chart on Medical - Year-over-year growth 2024-2029 (%); Data Table on Medical - Year-over-year growth 2024-2029 (%); 9.4 Recreational - Market size and forecast 2024-2029; Chart on Recreational - Market size and forecast 2024-2029 ($ billion); Data Table on Recreational - Market size and forecast 2024-2029 ($ billion); Chart on Recreational - Year-over-year growth 2024-2029 (%); Data Table on Recreational - Year-over-year growth 2024-2029 (%); 9.5 Market opportunity by Product; Market opportunity by Product ($ billion); Data Table on Market opportunity by Product ($ billion)
10 Market Segmentation by Source: 10.1 Market segments; Chart on Source - Market share 2024-2029 (%); Data Table on Source - Market share 2024-2029 (%); 10.2 Comparison by Source; Chart on Comparison by Source; Data Table on Comparison by Source; 10.3 Marijuana - Market size and forecast 2024-2029; Chart on Marijuana - Market size and forecast 2024-2029 ($ billion); Data Table on Marijuana - Market size and forecast 2024-2029 ($ billion); Chart on Marijuana - Year-over-year growth 2024-2029 (%); Data Table on Marijuana - Year-over-year growth 2024-2029 (%); 10.4 Hemp - Market size and forecast 2024-2029; Chart on Hemp - Market size and forecast 2024-2029 ($ billion); Data Table on Hemp - Market size and forecast 2024-2029 ($ billion); Chart on Hemp - Year-over-year growth 2024-2029 (%); Data Table on Hemp - Year-over-year growth 2024-2029 (%); 10.5 Market opportunity by Source; Market opportunity by Source ($ billion); Data Table on Market opportunity by Source ($ billion)
11 Customer Landscape: 11.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Drivers, Challenges, and Opportunity/Restraints: 12.1 Market drivers; 12.2 Market challenges; 12.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 12.4 Market opportunities/restraints
13 Competitive Landscape: 13.1 Overview; 13.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 13.3 Landscape disruption; Overview on factors of disruption; 13.4 Industry risks; Impact of key risks on business
14 Competitive Analysis: 14.1 Companies profiled; Companies covered; 14.2 Company ranking index; Company ranking index; 14.3 Market positioning of companies; Matrix on companies position and classification; 14.4 Canopy Growth Corp.; Canopy Growth Corp. - Overview; Canopy Growth Corp. - Business segments; Canopy Growth Corp. - Key news; Canopy Growth Corp. - Key offerings; Canopy Growth Corp. - Segment focus; SWOT; 14.5 Charlottes Web Holdings Inc.; Charlottes Web Holdings Inc. - Overview; Charlottes Web Holdings Inc. - Product / Service; Charlottes Web Holdings Inc. - Key news; Charlottes Web Holdings Inc. - Key offerings; SWOT; 14.6 Columbia Care Inc.; Columbia Care Inc. - Overview; Columbia Care Inc. - Product / Service; Columbia Care Inc. - Key offerings; SWOT; 14.7 Cresco Labs LLC; Cresco Labs LLC - Overview; Cresco Labs LLC - Product / Service; Cresco Labs LLC - Key offerings; SWOT; 14.8 Cronos Group Inc.; Cronos Group Inc. - Overview; Cronos Group Inc. - Business segments; Cronos Group Inc. - Key news; Cronos Group Inc. - Key offerings; Cronos Group Inc. - Segment focus; SWOT; 14.9 Curaleaf Holdings Inc.; Curaleaf Holdings Inc. - Overview; Curaleaf Holdings Inc. - Product / Service; Curaleaf Holdings Inc. - Key offerings; SWOT; 14.10 Green Roads Inc.; Green Roads Inc. - Overview; Green Roads Inc. - Product / Service; Green Roads Inc. - Key offerings; SWOT; 14.11 Lexaria Bioscience Corp.; Lexaria Bioscience Corp. - Overview; Lexaria Bioscience Corp. - Business segments; Lexaria Bioscience Corp. - Key offerings; Lexaria Bioscience Corp. - Segment focus; SWOT; 14.12 Medical Marijuana Inc.; Medical Marijuana Inc. - Overview; Medical Marijuana Inc. - Product / Service; Medical Marijuana Inc. - Key offerings; SWOT; 14.13 Pure Spectrum CBD; Pure Spectrum CBD - Overview; Pure Spectrum CBD - Key offerings; SWOT; 14.14 Terrascend Canada; Terrascend Canada - Overview; Terrascend Canada - Key offerings; SWOT; 14.15 Tilray Brands Inc.; Tilray Brands Inc. - Overview; Tilray Brands Inc. - Business segments; Tilray Brands Inc. - Key news; Tilray Brands Inc. - Key offerings; Tilray Brands Inc. - Segment focus; SWOT; 14.16 Trulieve Cannabis Corp.; Trulieve Cannabis Corp. - Overview; Trulieve Cannabis Corp. - Product / Service; Trulieve Cannabis Corp. - Key offerings; SWOT; 14.17 Unrivaled Brands Inc.; Unrivaled Brands Inc. - Overview; Unrivaled Brands Inc. - Business segments; Unrivaled Brands Inc. - Key offerings; Unrivaled Brands Inc. - Segment focus; SWOT; 14.18 Verano Holdings LLC; Verano Holdings LLC - Overview; Verano Holdings LLC - Business segments; Verano Holdings LLC - Key offerings; Verano Holdings LLC - Segment focus; SWOT
15 Appendix: 15.1 Scope of the report; 15.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 15.3 Currency conversion rates for US$; Currency conversion rates for US$; 15.4 Research methodology; Research methodology; 15.5 Data procurement; Information sources; 15.6 Data validation; Data validation; 15.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 15.8 Data synthesis; Data synthesis; 15.9 360 degree market analysis; 360 degree market analysis; 15.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by Derivative Type; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Source; Exhibits7: Executive Summary - Chart on Company Market Positioning; Exhibits8: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits9: Overview on criticality of inputs and factors of differentiation; Exhibits10: Overview on factors of disruption; Exhibits11: Impact of drivers and challenges in 2024 and 2029; Exhibits12: Parent Market; Exhibits13: Data Table on - Parent Market; Exhibits14: Market characteristics analysis; Exhibits15: Value chain analysis; Exhibits16: Offerings of companies included in the market definition; Exhibits17: Market segments; Exhibits18: Chart on US - Market size and forecast 2024-2029 ($ billion); Exhibits19: Data Table on US - Market size and forecast 2024-2029 ($ billion); Exhibits20: Chart on US: Year-over-year growth 2024-2029 (%); Exhibits21: Data Table on US: Year-over-year growth 2024-2029 (%); Exhibits22: Historic Market Size - Data Table on Cannabis Market in US 2019 - 2023 ($ billion); Exhibits23: Historic Market Size - Derivative Type Segment 2019 - 2023 ($ billion); Exhibits24: Historic Market Size - Product Segment 2019 - 2023 ($ billion); Exhibits25: Historic Market Size - Source Segment 2019 - 2023 ($ billion); Exhibits26: Five forces analysis - Comparison between 2024 and 2029; Exhibits27: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits28: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits29: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits30: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits31: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits32: Chart on Market condition - Five forces 2024 and 2029; Exhibits33: Chart on Derivative Type - Market share 2024-2029 (%); Exhibits34: Data Table on Derivative Type - Market share 2024-2029 (%); Exhibits35: Chart on Comparison by Derivative Type; Exhibits36: Data Table on Comparison by Derivative Type; Exhibits37: Chart on CBD - Market size and forecast 2024-2029 ($ billion); Exhibits38: Data Table on CBD - Market size and forecast 2024-2029 ($ billion); Exhibits39: Chart on CBD - Year-over-year growth 2024-2029 (%); Exhibits40: Data Table on CBD - Year-over-year growth 2024-2029 (%); Exhibits41: Chart on THC - Market size and forecast 2024-2029 ($ billion); Exhibits42: Data Table on THC - Market size and forecast 2024-2029 ($ billion); Exhibits43: Chart on THC - Year-over-year growth 2024-2029 (%); Exhibits44: Data Table on THC - Year-over-year growth 2024-2029 (%); Exhibits45: Chart on Balanced THC and CBD - Market size and forecast 2024-2029 ($ billion); Exhibits46: Data Table on Balanced THC and CBD - Market size and forecast 2024-2029 ($ billion); Exhibits47: Chart on Balanced THC and CBD - Year-over-year growth 2024-2029 (%); Exhibits48: Data Table on Balanced THC and CBD - Year-over-year growth 2024-2029 (%); Exhibits49: Market opportunity by Derivative Type ($ billion); Exhibits50: Data Table on Market opportunity by Derivative Type ($ billion); Exhibits51: Chart on Product - Market share 2024-2029 (%); Exhibits52: Data Table on Product - Market share 2024-2029 (%); Exhibits53: Chart on Comparison by Product; Exhibits54: Data Table on Comparison by Product; Exhibits55: Chart on Medical - Market size and forecast 2024-2029 ($ billion); Exhibits56: Data Table on Medical - Market size and forecast 2024-2029 ($ billion); Exhibits57: Chart on Medical - Year-over-year growth 2024-2029 (%); Exhibits58: Data Table on Medical - Year-over-year growth 2024-2029 (%); Exhibits59: Chart on Recreational - Market size and forecast 2024-2029 ($ billion); Exhibits60: Data Table on Recreational - Market size and forecast 2024-2029 ($ billion); Exhibits61: Chart on Recreational - Year-over-year growth 2024-2029 (%); Exhibits62: Data Table on Recreational - Year-over-year growth 2024-2029 (%); Exhibits63: Market opportunity by Product ($ billion); Exhibits64: Data Table on Market opportunity by Product ($ billion); Exhibits65: Chart on Source - Market share 2024-2029 (%); Exhibits66: Data Table on Source - Market share 2024-2029 (%); Exhibits67: Chart on Comparison by Source; Exhibits68: Data Table on Comparison by Source; Exhibits69: Chart on Marijuana - Market size and forecast 2024-2029 ($ billion); Exhibits70: Data Table on Marijuana - Market size and forecast 2024-2029 ($ billion); Exhibits71: Chart on Marijuana - Year-over-year growth 2024-2029 (%); Exhibits72: Data Table on Marijuana - Year-over-year growth 2024-2029 (%); Exhibits73: Chart on Hemp - Market size and forecast 2024-2029 ($ billion); Exhibits74: Data Table on Hemp - Market size and forecast 2024-2029 ($ billion); Exhibits75: Chart on Hemp - Year-over-year growth 2024-2029 (%); Exhibits76: Data Table on Hemp - Year-over-year growth 2024-2029 (%); Exhibits77: Market opportunity by Source ($ billion); Exhibits78: Data Table on Market opportunity by Source ($ billion); Exhibits79: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits80: Impact of drivers and challenges in 2024 and 2029; Exhibits81: Overview on criticality of inputs and factors of differentiation; Exhibits82: Overview on factors of disruption; Exhibits83: Impact of key risks on business; Exhibits84: Companies covered; Exhibits85: Company ranking index; Exhibits86: Matrix on companies position and classification; Exhibits87: Canopy Growth Corp. - Overview; Exhibits88: Canopy Growth Corp. - Business segments; Exhibits89: Canopy Growth Corp. - Key news; Exhibits90: Canopy Growth Corp. - Key offerings; Exhibits91: Canopy Growth Corp. - Segment focus; Exhibits92: SWOT; Exhibits93: Charlottes Web Holdings Inc. - Overview; Exhibits94: Charlottes Web Holdings Inc. - Product / Service; Exhibits95: Charlottes Web Holdings Inc. - Key news; Exhibits96: Charlottes Web Holdings Inc. - Key offerings; Exhibits97: SWOT; Exhibits98: Columbia Care Inc. - Overview; Exhibits99: Columbia Care Inc. - Product / Service; Exhibits100: Columbia Care Inc. - Key offerings; Exhibits101: SWOT; Exhibits102: Cresco Labs LLC - Overview; Exhibits103: Cresco Labs LLC - Product / Service; Exhibits104: Cresco Labs LLC - Key offerings; Exhibits105: SWOT; Exhibits106: Cronos Group Inc. - Overview; Exhibits107: Cronos Group Inc. - Business segments; Exhibits108: Cronos Group Inc. - Key news; Exhibits109: Cronos Group Inc. - Key offerings; Exhibits110: Cronos Group Inc. - Segment focus; Exhibits111: SWOT; Exhibits112: Curaleaf Holdings Inc. - Overview; Exhibits113: Curaleaf Holdings Inc. - Product / Service; Exhibits114: Curaleaf Holdings Inc. - Key offerings; Exhibits115: SWOT; Exhibits116: Green Roads Inc. - Overview; Exhibits117: Green Roads Inc. - Product / Service; Exhibits118: Green Roads Inc. - Key offerings; Exhibits119: SWOT; Exhibits120: Lexaria Bioscience Corp. - Overview; Exhibits121: Lexaria Bioscience Corp. - Business segments; Exhibits122: Lexaria Bioscience Corp. - Key offerings; Exhibits123: Lexaria Bioscience Corp. - Segment focus; Exhibits124: SWOT; Exhibits125: Medical Marijuana Inc. - Overview; Exhibits126: Medical Marijuana Inc. - Product / Service; Exhibits127: Medical Marijuana Inc. - Key offerings; Exhibits128: SWOT; Exhibits129: Pure Spectrum CBD - Overview; Exhibits130: Pure Spectrum CBD - Key offerings; Exhibits131: SWOT; Exhibits132: Terrascend Canada - Overview; Exhibits133: Terrascend Canada - Key offerings; Exhibits134: SWOT; Exhibits135: Tilray Brands Inc. - Overview; Exhibits136: Tilray Brands Inc. - Business segments; Exhibits137: Tilray Brands Inc. - Key news; Exhibits138: Tilray Brands Inc. - Key offerings; Exhibits139: Tilray Brands Inc. - Segment focus; Exhibits140: SWOT; Exhibits141: Trulieve Cannabis Corp. - Overview; Exhibits142: Trulieve Cannabis Corp. - Product / Service; Exhibits143: Trulieve Cannabis Corp. - Key offerings; Exhibits144: SWOT; Exhibits145: Unrivaled Brands Inc. - Overview; Exhibits146: Unrivaled Brands Inc. - Business segments; Exhibits147: Unrivaled Brands Inc. - Key offerings; Exhibits148: Unrivaled Brands Inc. - Segment focus; Exhibits149: SWOT; Exhibits150: Verano Holdings LLC - Overview; Exhibits151: Verano Holdings LLC - Business segments; Exhibits152: Verano Holdings LLC - Key offerings; Exhibits153: Verano Holdings LLC - Segment focus; Exhibits154: SWOT; Exhibits155: Inclusions checklist; Exhibits156: Exclusions checklist; Exhibits157: Currency conversion rates for US$; Exhibits158: Research methodology; Exhibits159: Information sources; Exhibits160: Data validation; Exhibits161: Validation techniques employed for market sizing; Exhibits162: Data synthesis; Exhibits163: 360 degree market analysis; Exhibits164: List of abbreviations